ClinVar Miner

Submissions for variant NM_000322.5(PRPH2):c.554T>C (p.Leu185Pro)

gnomAD frequency: 0.00001  dbSNP: rs121918563
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 10
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000084987 SCV000567191 pathogenic not provided 2017-04-17 criteria provided, single submitter clinical testing The L185P variant was reported in 3 families where it functioned as a recessive variant only resultingin a disease phenotype when inherited with a null (loss-of-function) variant in the ROM1 gene ( Kajiwaraet al. 1994). Therefore the L185P variant in the PRPH2 gene and a null variant in the ROM1 genecause a digenic form of retinitis pigmentosa. The L185P substitution has also been reported previously as anapparently homozygous variant in association with Leber congenital amaurosis (Wang et al., 2013). TheL185P variant was not observed in approximately 6,500 individuals of European and African Americanancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in thesepopulations. The L185P variant is a semi-conservative amino acid substitution that occurs at a positionthat is conserved across species. In silico analysis predicts this substitution is probably damaging to theprotein structure/function. Therefore, L185P is interpreted to be a pathogenic variant.
Blueprint Genetics RCV001075516 SCV001241142 pathogenic Retinal dystrophy 2018-11-19 criteria provided, single submitter clinical testing
NEI Ophthalmic Genomics Laboratory, National Institutes of Health RCV001250378 SCV001424714 likely pathogenic Patterned dystrophy of the retinal pigment epithelium 2020-01-07 criteria provided, single submitter clinical testing The variant NM_000322.4:c.554T>C in the PRPH2 gene has been previously studied(PMIDs 1684223, 8202715, 10800708, 12925772). We found this variant in 1 patient(s) in a PRPH2 cohort study (Reeves et al. 2020). This variant is listed in dbSNP and/or HGMD (rs121918563,CM910323). It is present in gnomAD browser (AF 0.00000812). It is not enriched in the PRPH2 disease cohort. We invoked ACMG criteria [PP1-M, PM1, PM2, PP3, PP5] and classified NM_000322.4:c.554T>C in the PRPH2 gene as a Likely Pathogenic mutation.
Ocular Genomics Institute, Massachusetts Eye and Ear RCV000149466 SCV001573365 likely pathogenic Patterned macular dystrophy 1 2021-04-08 criteria provided, single submitter research The PRPH2 c.554T>C variant was identified in an individual with retinitis pigmentosa with a presumed dominant inheritance pattern. Through a review of available evidence we were able to apply the following criteria: PS3, PM2, PP3. Based on this evidence we have classified this variant as Likely Pathogenic.
Invitae RCV001378481 SCV001576053 pathogenic PRPH2-Related Disorders 2023-06-15 criteria provided, single submitter clinical testing For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this missense change affects PRPH2 function (PMID: 8943002, 11297544, 11427722, 12925772). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PRPH2 protein function. ClinVar contains an entry for this variant (Variation ID: 13165). This missense change has been observed in individuals with autosomal recessive and autosomal dominant retinal dystrophy. This variant may be associated with a milder, later-onset form of autosomal dominant retinal dystrophy (PMID: 1684223, 8202715, 9331261, 16799052, 23847139, 26720483, 32531846; Invitae). This variant is present in population databases (rs121918563, gnomAD 0.002%). This sequence change replaces leucine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 185 of the PRPH2 protein (p.Leu185Pro).
OMIM RCV000014051 SCV000034298 pathogenic Retinitis pigmentosa 7, digenic 2013-10-01 no assertion criteria provided literature only
Retina International RCV000084987 SCV000117123 not provided not provided no assertion provided not provided
OMIM RCV000149464 SCV000196108 pathogenic Leber congenital amaurosis 18 2013-10-01 no assertion criteria provided literature only
OMIM RCV000149466 SCV000196110 pathogenic Patterned macular dystrophy 1 2013-10-01 no assertion criteria provided literature only
Leiden Open Variation Database RCV001530305 SCV001745074 likely pathogenic Retinitis pigmentosa 2021-04-06 no assertion criteria provided curation Curator: Global Variome, with Curator vacancy. Submitters to LOVD: Feng Wang, Julia Lopez, Manon Peeters.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.